Showing 81 - 100 results of 514 for search 'Cancer risk assessment', query time: 0.10s Refine Results
  1. 81
  2. 82

    The value and application of a poorly differentiated cluster-based Ezrin marginal score system in the prognostic assessment of colorectal cancer by Yangyang Jiang, Ling Liu, Yingying Chang, Limei Gu, Yaohui Wang, Ting-Sheng Ling, Xiaolong Zhang

    Published 2025-08-01
    “…Abstract Aim This study aimed to explore the distribution of Ezrin-positive cells in poorly differentiated cluster (PDC) of colorectal cancer (CRC), and its correlation with both traditional and auxiliary pathological indicators, including E-cadherin and tumor-stroma ratio (TSR), as well as patient prognosis. …”
    Get full text
    Article
  3. 83

    Ecotoxicological health risk analysis of different fish species from the Black Sea coast of Türkiye by Evrim Sibel ÖNEL, Mustafa TÜRKMEN, Erkan KALIPCI

    Published 2025-08-01
    “…Furthermore, human health risk assessment from fish consumption was investigated using multiple statistical approaches, and a spatial distribution map of PTEs in the region was prepared. …”
    Get full text
    Article
  4. 84

    Immunoassayofantibodies to benzo[a]pyrene, estradiol and progesterone fordeterminationofpersonal lung cancer riskinmen by A. N. Glushkov, E. G. Polenok, S. A. Mun, L. A. Gordeeva, M. V. Kostyanko, Y. A. Magarill, V. A. Titov, N. E. Verzhbitskaya, I. A. Vafin

    Published 2019-04-01
    “…A personalized lung cancer risk assessment is important for disease prevention.The aim of the studywas to estimate a significance of immunoanalysis of antibodies to benzo[a]pyrene, estradiol and progesterone for lung cancer risk prediction in men with respect to age and smoking.Material and methods. …”
    Get full text
    Article
  5. 85

    Transformative insights from transcriptome analysis of colorectal cancer patient tissues: identification of four key prognostic genes by Nevin Belder, Sulgun Charyyeva, Edibe Ece Abaci Oruc, Hakiimu Kawalya, Namood-e Sahar, Nader Omidvar, Berna Savas, Arzu Ensari, Hilal Ozdag

    Published 2025-08-01
    “…In conclusion, our risk assessment model exhibits strong potential for predicting poor survival and unfavorable clinicopathological features in CRC patients, offering valuable insights for personalised management strategies.…”
    Get full text
    Article
  6. 86

    Targeted Metabolomic Serum Analysis of Patients with High and Low Risk of Endometrial Cancer Recurrence and Positive and Negative Lymph Node Status by Dagmara Pietkiewicz, Mikołaj Piotr Zaborowski, Szymon Plewa, Michał Potograbski, Cezary Miedziarek, Tomasz Kluz, Ewa Nowak-Markwitz, Jan Matysiak

    Published 2025-06-01
    “…Thus, targeted metabolomic serum profiling might be a powerful tool for improving risk assessment, enabling more personalized therapeutic approaches and management strategies in endometrial cancer.…”
    Get full text
    Article
  7. 87
  8. 88
  9. 89

    Comparative analysis and optimization of tumor regression grade assessment systems in neoadjuvant therapy for esophageal squamous cell carcinoma by Qiao Yang, Xiaoqing Zhou, Jiayu Li, Jieyu Wang, Jingcheng Luo, Dan Luo, Lin Shi, Chengmin Zhou, Yi Wang, Xuefeng Leng, Qifeng Wang, Yang Liu, Yehan Zhou

    Published 2025-08-01
    “…Abstract Objective This study aims to compare and analyze the effectiveness of different tumor regression grade (TRG) assessment systems in evaluating neoadjuvant therapy for esophageal cancer, with the goal of identifying an optimal assessment method to guide clinical practice. …”
    Get full text
    Article
  10. 90

    CYP2D6-GENOTYPING IN THE ASSESSMENT OF THE EFFECTIVENESS OF THERAPY WITH TAMOXIFEN IN PATIENTS WITH ADVANCED HORMONE RECEPTOR-POSITIVE BREAST CANCER by L. N. Lyubchenko, M. G. Filippova, N. I. Mekhtieva, T. A. Shendrikova, A. V. Semaynikhina, A. V. Snegovoy

    Published 2017-12-01
    “…Pharmacogenetic testing of the CYP2D6 gene in patients with hormone-positive breast cancer can help to predict response to therapy and assess the risk of side effects with the aim of improving long-term treatment outcomes.…”
    Get full text
    Article
  11. 91
  12. 92

    Methods for Preclinical Assessment of the Efficacy of Anticancer Medicines <i>in vivo</i> (Review) by M. L. Vasyutina, K. V. Lepik, M. S. Istomina, K. A. Levchuk, A. V. Petukhov, E. V. Shchelina, A. E. Ershova, O. N. Demidov, Ya. G. Toropova

    Published 2025-07-01
    “…INTRODUCTION. The main risk to the clinical translatability of preclinical results for anticancer medicinal products is posed by the difficulty of simulating clinical conditions in an experimental model. …”
    Get full text
    Article
  13. 93
  14. 94

    Association between GLP-1 receptor agonists as a class and colorectal cancer risk: a meta-analysis of retrospective cohort studies by Ying Zhong, Tingting Wu, Najeeb Ullah Khan

    Published 2025-08-01
    “…While these medications offer glycemic control and cardiovascular benefits, the risks have increased because of their potential impact on cancer risk, particularly colorectal cancer (CRC). …”
    Get full text
    Article
  15. 95

    Belatacept and non-melanoma skin cancer risk in kidney transplant recipients: a narrative review from a mechanistic and clinical perspective by Hany M. El Hennawy, Omar Safar, Ahmed Nassar, Mahmoud Z. El Madawie, Mohammad F. Zaitoun, Yasser M. Almahdi, Abdullah S. Al Faifi, Ibrahim Tawhari

    Published 2025-08-01
    “…Secondary objectives include evaluating the immunologic mechanisms underlying its distinct cancer risk profile, exploring combinatory regimens (particularly with mammalian target of rapamycin inhibitors), assessing metabolic and nephrotoxic implications, and addressing ethical and clinical considerations in switching stable patients from Calcineurin inhibitors to belatacept. …”
    Get full text
    Article
  16. 96

    Extracorporeal Detoxification Methods and Hemostasis System for Ovarian Cancer Patients. Clinical Case by A. S. Safonov, M. V. Zabelin, A. A. Izmailov, Z. A. Valiullina, A. R. Mukhametkulova, A. V. Vasilchenko, K. N. Zolotukhin

    Published 2023-07-01
    “…The clinical case was assessed in terms of P-selectin (CD62), which characterizes platelet activation processes. …”
    Get full text
    Article
  17. 97
  18. 98

    Enhancing risk stratification in diabetic gastric cancer: muscle-fat ratio from photon-counting CT as a predictor of postoperative complications by Shuangxiang Lin, Yuchen Jin, Mengxi Xu, Shuyue Wang, Weisheng Yao, Jiaxing Wu, Xinhong Wang, Jianzhong Sun

    Published 2025-08-01
    “…We evaluated whether Photon-counting CT (PCD-CT) derived MFR predicts major postoperative complications, reflecting its value in perioperative risk stratification. Methods A retrospective analysis of 134 gastric cancer patients with type 2 diabetes was conducted. …”
    Get full text
    Article
  19. 99

    A predictive nomogram for assessing the likelihood of retrieving 12 lymph nodes after rectal cancer surgery: a single-center study by Jian Ma, Runyang Hao, Shuai Jiao, Qingmin Chen, Baohong Yang, Xu Guan, Jiale Li, Xinxuan Zhao, Yu Huo, Qingxia Xu, Haiyi Liu, Wen Su, Xishan Wang

    Published 2025-08-01
    “…ObjectiveThe retrieval of 12 lymph nodes (LNs) remains a crucial criterion for accurate staging and prognosis evaluation in rectal cancer (RC). However, some patients fail to meet this threshold after surgery. …”
    Get full text
    Article
  20. 100